Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers
- 1 May 2001
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (8), 1033-1040
- https://doi.org/10.1016/s0959-8049(01)00077-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Deregulation of the signaling pathways controlling urokinase productionEuropean Journal of Biochemistry, 1999
- In vivo analysis of the state of the human uPA enhancer following stimulation by TPAOncogene, 1999
- Molecular phylogeny of the ETS gene familyOncogene, 1999
- ETS2 function is required to maintain the transformed state of human prostate cancer cellsOncogene, 1998
- A new member of the ETS family fused to EWS in Ewing tumorsOncogene, 1997
- Identification of differentially expressed prostate genes: Increased expression of transcription factor ETS-2 in prostate cancerThe Prostate, 1997
- Urokinase-Type Plasminogen Activator Expression in Human Prostate CarcinomasThe American Journal of the Medical Sciences, 1996
- Activation and inhibition of the AP-1 complex in human breast cancer cellsMolecular Carcinogenesis, 1996
- c‐jun oncogene expression in transitional cell carcinoma of the urinary bladderBritish Journal of Urology, 1994
- Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signalsCell, 1990